NAFDAC Defends Drug Market Crackdown, Says Fines Are Lawful
NAFDAC DG
The National Agency for Food and Drug Administration and Control (NAFDAC) has defended the legality of charges levied against drug traders during its recent enforcement sweep, dismissing allegations of extortion and arbitrary penalties.
Speaking at a press briefing in Lagos on Friday, the Director General of NAFDAC, Prof Mojisola Adeyeye, said the agency’s actions across major drug markets in Idumota (Lagos), Ariaria (Aba), and Bridge Head (Onitsha) between February 9 and March 27, 2025, were guided strictly by existing laws.
“Let it be made abundantly clear: every charge imposed was in line with federal regulations and duly gazetted by the government,” Prof Adeyeye stated.
“There was no witch-hunt, no arbitrary enforcement. These were consequences of clear violations of public health laws.”
NAFDAC said it sealed off shops, warehouses, and distribution hubs dealing in unregistered, expired, falsified, and banned drugs, including some diverted from donation programmes.
The crackdown reportedly led to the removal of over ₦1 trillion worth of dangerous pharmaceuticals from public circulation.
“We cannot allow a system where people peddle poisons in the name of medicine,” she declared.
“Our actions were not only lawful—they were absolutely necessary to save lives.”
Prof Adeyeye also clarified that investigative charges issued to violators were not arbitrarily determined.
“These fines were not invented by NAFDAC overnight. They are rooted in official policy,” she said.
“The reductions were granted in good faith after careful consideration of appeals. This is a system based on fairness and legality.”
Following the enforcement, the Ogbogwu drug market in Onitsha long considered the epicentre of fake pharmaceuticals in West Africa was officially reopened on March 9, 2025, after 2,500 traders with 3,500 shops met NAFDAC’s compliance conditions.
“We are not shutting businesses down permanently,” Prof Adeyeye explained.
“We are restructuring the system for safety and accountability. There is unconditional reopening for those who comply.”
Highlighting the dangers of counterfeit drugs, the DG stressed that fake antihypertensives, expired antibiotics, and banned narcotics were responsible for “countless avoidable deaths” across the country.
“We cannot afford to lose more pregnant women, children, or chronically ill patients to counterfeit medicine,” she said.
“This is our mandate, and we will not relent.”
NAFDAC vowed to sustain its surveillance and enforcement campaigns nationwide in its quest to ensure only safe, effective, and quality-assured medical products remain in circulation.
